Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesNexgenRX Inc.

NexgenRX Inc.

Healthcare Health Information Services
PortfolioPortfolio WatchlistWatchlist
Company price
0.66 CAD 0.00(0%)
Last update at 2026-11-03T20:13:00Z
VOLUME
441
Market Cap
27.74M
P/E
39.00

Momentum Score

…

NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. The company offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. It also provides ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.66
Low
0.66
High
52 Week Price Range
0.26
Low
0.44
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public disclosures for NexgenRX Inc. (NXG.V) are limited and the company's core business and long-term growth drivers are not clearly described in readily available filings. Investors may find exposure to a small-cap TSX Venture‑listed issuer of interest, but they should consult the company’s regulatory filings and management discussion for verified strategy and catalysts.
Key risks include sparse public disclosure, limited operating history, likely low liquidity, and material financing and execution risk common to small-cap TSXV issuers.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.66
Dividend Yield
3.85%
Revenue TTM
17.93M
Revenue Per Share
0.25
Gross Profit TTM
14.93M
Debt / Equity
-
ROE
16.92%
Net Debt
-
ROCE
28.24%
Diluted EPS TTM
0.01

Insight News

View All

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 1.94M 1.03M -0.31M 0.13M 2.01M
Net income 1.29M 0.61M -0.33M -0.02M 4.02M
Selling general administrative 1.57M 1.38M 1.27M 1.27M 6.28M
Gross profit 14.93M 13.12M 10.82M 10.18M 9.81M
Reconciled depreciation 1.22M 1.27M 1.31M 1.41M 1.33M
Ebit - - - - 2.20M
Ebitda - - - 1.56M 3.40M
Operating income 2.23M 1.20M -0.14M 0.29M 2.20M
Interest expense 0.03M 0.03M 0.03M 0.02M 0.06M
Tax provision 0.65M 0.41M 0.03M 0.16M -2.01M
Net interest income -0.17M -0.17M -0.16M -0.15M -0.19M
Income tax expense - - - 0.16M -2.01M
Total revenue 17.93M 16.48M 13.85M 12.78M 11.84M
Total operating expenses 15.70M 15.28M 13.99M 12.49M 9.64M
Cost of revenue 3.00M 3.35M 3.03M 2.60M 2.03M
Total other income expense net -0.12M - - - -
Net income from continuing ops 1.29M 0.61M -0.33M -0.02M 4.02M
Net income applicable to common shares - - - - 3.89M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 36.60M 30.46M 30.20M 25.75M 29.44M
Intangible assets 1.40M 2.33M 3.15M 4.10M 5.12M
Other current assets - - - - 17.87M
Total liab 28.98M 22.84M 22.48M 16.90M 19.72M
Total stockholder equity 7.62M 7.62M 7.71M 8.85M 9.71M
Other current liab 26.63M 21.80M 20.42M 15.54M 17.91M
Common stock - - - 19.29M 19.29M
Capital stock 5.66M 5.66M 5.47M 20.94M 20.94M
Retained earnings -2.44M -2.43M -2.14M -16.43M -15.53M
Good will 1.08M 1.24M 1.24M 1.24M 1.24M
Other assets - - - - 1.74M
Cash 4.78M 1.71M 1.88M 1.77M 2.32M
Total current liabilities 28.69M 22.41M 22.08M 16.51M 19.55M
Property plant equipment - - - 0.84M 0.50M
Total current assets 32.40M 24.65M 23.34M 18.00M 20.83M
Long term investments 0.37M 0.18M - - -
Net tangible assets - - - - 1.71M
Net receivables 0.73M 0.82M 0.73M 0.41M 0.48M
Accounts payable 1.98M 0.50M 1.18M 0.92M 1.41M
Non current assets total 4.20M 5.81M 6.85M 7.74M 8.60M
Capital lease obligations 0.37M 0.53M 0.46M 0.43M 0.40M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -0.18M -0.18M 0.00M -0.51M -1.37M
Change to liabilities - - - 0.00M 0.54M
Total cashflows from investing activities - - - - -1.37M
Net borrowings -0.11M -0.10M -0.08M -0.21M -0.81M
Total cash from financing activities -1.41M -0.82M -0.92M -1.11M -0.94M
Change to operating activities - - - - 0.01M
Net income 1.29M 0.61M -0.33M -0.02M 4.02M
Change in cash 3.07M -0.17M 0.11M -0.55M 1.52M
Begin period cash flow 1.71M 1.88M 1.77M 2.32M 0.80M
End period cash flow 4.78M 1.71M 1.88M 1.77M 2.32M
Total cash from operating activities 4.98M 1.15M 1.28M 1.07M 3.82M
Issuance of capital stock 0.00M 0.19M 0.06M - -
Depreciation 1.22M 1.27M 1.31M 1.41M 1.33M
Dividends paid -1.30M 0.91M 0.90M 0.90M 0.13M
Change to account receivables 0.10M -0.10M -0.32M 0.07M -0.12M
Change to netincome - - - - -1.95M
Capital expenditures 0.35M 0.32M 0.25M 0.39M 0.13M
Change in working capital 1.67M -1.14M 0.23M -0.58M 0.43M
Stock based compensation 0.01M 0.02M 0.04M 0.06M 0.10M
Other non cash items 0.03M 0.03M 0.03M -0.20M -0.03M
Free cash flow 4.63M 0.83M 1.03M 0.56M 2.45M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
NXG
NexgenRX Inc.		 -
-%		 0.66 39.00 32.68 1.55 4.64 1.39 7.84
NURS
Hydreight Technologies Inc		 -0.03
0.99%		 2.99 406.00 25.91 7.85 20.38 7.45 109.02
ADK
Diagnos Inc		 -0.01
2.82%		 0.34 - 10.00 411.24 18.74 389.06 -6.16
PTEC
Principal Technologies Inc		 -
-%		 0.32 - - 62.75 355.42 72.08 -0.81
CHS
Comprehensive Healthcare Systems Inc		 -
-%		 0.33 - - 4.44 13.23 3.83 26.88

Profile*

NexgenRX Inc.

NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. The company offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. It also provides ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.

191 The West Mall, Toronto, ON, Canada, M9C 5K8

416 695 3393

https://www.nexgenrx.com

Name Title Year Born
Mr. Ronald C. Loucks B.B.A. Founder, CEO, Pres & Director 1950
Mr. Kelly Elher C.A., CPA, CA, CPA Chief Financial Officer NA
Mr. Andrew Munroe Sr. VP of Pharma & Payor Partners NA
Mr. Jason Robinson Sr. VP of Admin. NA
Ms. Doreen Harvey Lead HR NA
Mr. Paul Anthony Bolger LL.B., M.B.A. Company Sec. NA
Mr. Avik Debroy Financial Controller NA
Mr. Ronald C. Loucks B.B.A. Founder, CEO, President & Director 1950
Mr. Andrew Munroe Vice President of Operations NA
Mr. Jason Robinson Vice President of Administration NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 30.34
+14.45%
OMG
CAD 1.70
+13.76%
ARTG
CAD 39.54
+12.59%
DSV
CAD 10.83
+12.58%
TLRY
CAD 4.17
+12.10%
DRUG
CAD 25.95
-30.02%
HUT
CAD 69.16
-22.20%
UCU
CAD 2.04
-16.39%
PHX
CAD 10.70
-15.62%
VET
CAD 15.04
-13.31%

Equity Sectors*

  • Basic Materials

    +4.80%

  • Communication Services

    +2.78%

  • Consumer Cyclical

    +2.82%

  • Consumer Defensive

    +0.74%

  • Energy

    -4.92%

  • Financial Services

    +2.47%

  • Healthcare

    -0.30%

  • Industrials

    -0.38%

  • Real Estate

    +1.75%

  • Technology

    +0.82%

  • Utilities

    +1.29%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…